My main research interest is in identifying biomarkers for early detection of Alzheimer’s disease pathology before clinical symptoms. Although I primarily evaluate neuroimaging measures from magnetic resonance imaging (MRI) and positron emission tomography (PET) techniques, I have significant interest in developing novel biomarkers. I am particularly interested in visual, olfactory, and other sensory measures as potential biomarkers of AD pathology in early stages of disease. I am interested in studying the impact of co-morbid medical and lifestyle factors, including vascular diseases, medications, and diet and exercise, on risk for and neuroimaging biomarkers of dementia. Finally, I have an interest in identifying and evaluating genetic variations that are associated with AD pathology using biomarkers as endophenotypes.
- Alzheimer’s Disease and Other Neurodegenerative Diseases and Dementias, Normal Aging, Co-Morbid Medical and Lifestyle Risk Factors for Cognitive Impairment, Memory and Cognition
- Alzheimer’s Disease and Other Neurodegenerative Diseases
- Neurodegenerative Disorders Research
- Neuroimaging (in vivo) Research
- Ocular Neurobiology Research